Does EMPAGLIFLOZIN Cause Vascular graft? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Vascular graft have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.
27
Reports of Vascular graft with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
0
Deaths
15
Hospitalizations
How Dangerous Is Vascular graft From EMPAGLIFLOZIN?
Of the 27 reports, 15 (55.6%) required hospitalization.
Is Vascular graft Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Vascular graft?
ROSIGLITAZONE (561)
RANOLAZINE (96)
INSULIN GLARGINE (77)
EVOLOCUMAB (69)
ADALIMUMAB (67)
ETANERCEPT (60)
METFORMIN\ROSIGLITAZONE (53)
AVANDIA (36)
DUPILUMAB (34)
RISANKIZUMAB-RZAA (26)
Which EMPAGLIFLOZIN Alternatives Have Lower Vascular graft Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE